Blog Posts
Are “New” Substance Abusers Slipping By Your Drug Test?
COVID Border Closures Thwart Drug raffickers.
Safety Has No Secrets: Psychemedics Overview
Rebuilding A Workplace After COVID-19 (Part Three of Three)
Rebuilding A Workplace After COVID-19 (Part Two of Three)
Rebuilding A Workplace After COVID-19 (Part One of Three)
Psychemedics Announces a “Vaping Panel” to Detect and Deter the use of Marijuana, CBD and Nicotine
A New and Cost-Effective Tool to Combat the E-cigarette Epidemic Among Youth ACTON, MA, May 5, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced a Vaping Panel to detect the use of Marijuana, CBD and Nicotine. This test provides a … Read more
Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA
A New and Cost-Effective Tool to Detect and Deter Nicotine use ACTON, MA, April 29, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the first FDA-cleared hair test for cotinine, the predominant metabolite for nicotine. This test provides a way … Read more
Psychemedics Statement on COVID-19 from CEO Ray Kubacki
To our clients, friends, and partners: In this time of uncertainty, we are taking steps to continue delivering the superior levels of service for which Psychemedics has become known. First, as with many of you, our people are our most valued asset and safeguarding their well-being is a top priority. With that in mind, we … Read more